Gustavo Henrique Xavier Caseiro

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background Hematopoietic stem cell transplantation (HSCT) can be used in the treatment of patients with refractory Crohn's disease (CD) when no alternative treatment is available. However, HSCT increases the risk of infections, in particular during the aplasia of mobilization and conditioning. Moreover, intestinal stomas in CD augment the risk of morbidity(More)
  • 1